AstraZeneca may have washed its hands of AZD4041 after the potential opioid use disorder (OUD) therapy demonstrated a drug-drug interaction last year, but the pharma’s development partner Eolas The | ...

Black patients presenting to the ED for an opioid overdose are less likely to receive outpatient referrals for opioid use disorder.

Eolas Therapeutics today announced that it has entered into a new agreement with AstraZeneca to assume full development ...

Black patients presenting to the emergency department for an opioid overdose are less likely to receive outpatient referrals ...

First responders in Vancouver can now administer a life-saving medication used to treat opioid-use disorder, following the ...

Contingency management interventions for stimulant and opioid use disorders should offer $128 per week for vouchers or $55 ...

OpEd: Insurance companies are blocking the best treatments that help patients ease pain without opioids. This must change.

HACKENSACK, NJ - The $45 million New Jersey received in opioid settlement money may not be given to community-based programs ...

Ninety-three percent of the people seen at Codac are on Medicaid. Most of them are covered through Neighborhood Health plan, ...

Kratom, a dietary supplement used for pain relief, anxiety, and energy, has been linked to an increase in substance use ...

During her remarks, the Governor will update attendees on her Administration’s work to prevent and respond to substance use ...